Ontology highlight
ABSTRACT: Due to the paucity of patient derived models in rare cancers, identification of therapeutic targets remains challenging. We developed a patient derived model, CLF-PED-015-T, from a patient with an undifferentiated sarcoma. From this model, we performed pooled RNAi and CRISPR-Cas9 negative selection screens and integrated that with a small molecule screen. Integration of these data identified CDK4 and XPO1 as potential therapeutic targets.
SECONDARY ACCESSION(S): PRJNA321575PRJNA321574
REPOSITORIES: dbGaP
Items per page: 5 1 - 5 of 15 |